All courses, faculty listings, and curricular and degree requirements described herein are subject to change or deletion without notice.
The master of science (MS) in drug development and product management has three aims: first, to give experienced professionals insight into the process of successful drug product development and deployment; second, to endow students with requisite knowledge and skills to collaborate effectively in the ongoing management of drug products; and third, to provide a solid, practical bridge to employment opportunities in pharmaceutical and managed care industries or related government agencies such as the US Food and Drug Administration (FDA) or the European Medicines Agency (EMA).
Distinctive features of the program include instruction by a combination of faculty who possess scholarly understanding and industry experience, a case-and project-oriented approach to learning, options in professional focus, online and face-to-face course delivery alternatives, and exposure to student colleagues with varied professional backgrounds.
The MS in drug development and product management is a full-time, self-supporting degree program with a required course schedule that takes three consecutive quarters to complete. The UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences is responsible for the academic management of the curriculum. UC San Diego Extension administers the program and provides student advising and career counseling services.
New students are admitted in the fall quarter of each academic year. Prospective candidates should submit an official UC San Diego online graduate application for admission (which includes a detailed statement of personal intent regarding the program), the application fee, one set of official transcripts from each institution attended after high school, three letters of professional recommendation, and a current résumé or curriculum vitae. At the discretion of the admissions committee, a personal interview may be required. The GRE/GMAT is not required; candidates should have an undergraduate degree and a minimum of two years of full-time work experience at the professional level. International applicants must submit official scores from the Test of English as a Foreign Language (TOEFL). The application deadline is June 1, 2020.
The degree program is designed to be completed in three consecutive quarters, studying full time. Classes are scheduled in the late afternoons and evenings during the workweek to accommodate part-time employment. Students are required to complete thirty-six units of course work for the degree. Successful completion of a master’s comprehensive examination is also required at the end of the program.
DDPM 200. Opportunities in Pharma, Biotech, and Managed Care (1)
DDPM 201. Pharmacotherapy and Diseases (3)
DDPM 202. Pharmaceutics for Small Molecules and Macromolecules (4)
DDPM 203. Pre-Clinical and Clinical Regulatory Submissions and Strategy (4)
DDPM 204. Clinical Trial Development from Phase 0 to Phase 3 Studies (4)
DDPM 208. Principles of Marketing Strategy, Product Value, and Life Cycle Management (4)
DDPM 210. Biologics and Biosimilars Drug Development (4)
DDPM 211. Managed Markets: Post-Marketing Drug Utilization Management (4)
DDPM 213. Health Outcomes Evidence (4)
DDPM 214. Business Development, Entrepreneurship, Corporate, and Intellectual Property Strategy (4)